Catalyst Pharmaceuticals, Inc. - Common Stock (NQ:CPRX)

In a welcome move, Amicus Therapeutics stock saw its Relative Strength Rating rise from 69 to 74 on Tuesday.

Assessing Catalyst Pharmaceuticals: Insights From 4 Financial Analysts ↗

March 07, 2024

Via Benzinga

Amicus Therapeutics Stock Sees RS Rating Improve To 74 ↗

March 05, 2024

All three have exciting programs on the way.

3 Biopharma Stocks You Don't Want to Miss in the New Bull Market ↗

March 05, 2024

As of Feb. 29, 2024, three stocks in the health care sector could be flashing a real warning to investors who value momentum as a key criteria in their trading decisions.

Top 3 Health Care Stocks You May Want To Dump In Q1 ↗

February 29, 2024

Via Benzinga

Earnings Preview For Catalyst Pharmaceuticals ↗

February 27, 2024

Via Benzinga

Why Catalyst Pharmaceuticals Stock Is Trading Lower ↗

January 05, 2024

Catalyst Pharmaceuticals Inc (NASDAQ: CPRX) shares are trading lower by 13% to $14.89 Friday morning.

Via Benzinga

Recap: Catalyst Pharmaceuticals Q3 Earnings ↗

November 08, 2023

Via Benzinga

Why the growth investor may take a look at NASDAQ:CPRX. ↗

August 21, 2023

CATALYST PHARMACEUTICALS INC (NASDAQ:CPRX) may be suited for growth investing, we'll explore why in this article.

Via Chartmill

Jim Cramer Likes This Bank 'Very, Very Much,' Says Stock Is Up 7% Over Past 6 Months ↗

January 22, 2024

On CNBC’s "Mad Money Lightning Round," Jim Cramer said Stanley Black & Decker, Inc.

Via Benzinga

Next Big Thing: 3 Biotech Stocks to Watch for Groundbreaking Advances ↗

January 18, 2024

With our improving economy, you need to invest in these top biotech stocks that are looking to strike gold this year.

These companies are still in the early innings of their growth potential.

Topics Economy

3 Biotech Stocks You Can Buy and Hold for the Next Decade ↗

January 15, 2024

With multiple drugs on the market and revenue ramping up, the sky's the limit.

Forget Shiba Inu: This Stock is Poised for a Potential Bull Run in 2024 ↗

January 14, 2024

Small-cap stocks tend to outperform mid- and large-cap stocks over time and make for an important component of a balanced portfolio.

3 Unstoppable S&P 600 Small-Cap Stocks to Buy in January ↗

January 08, 2024

Why Applied Therapeutics Shares Are Trading Lower By Over 35%? Here Are Other Stocks Moving In Friday's Mid-Day Session ↗

Topics Stocks

January 05, 2024

Shares of Applied Therapeutics, Inc.

Via Benzinga

Eli Lilly, Crispr, Biogen Lead Pharma And Biotech Stocks To Great Expectations In 2024 ↗

January 05, 2024

Between buyouts, obesity drugs and neuroscience progress, biotech stocks stand to gain.

Franklin Covey Shares Fall After Q1 Results, Joins Theravance Biopharma, Voyager Therapeutics And Other Big Stocks Moving Lower In Friday's Pre-Market Session ↗

January 05, 2024

U.S. stock futures were lower this morning, with the Dow Jones futures falling around 50 points on Friday.

Via Benzinga

Topics Stocks

Amgen Stock Sees Relative Strength Rating Improve To 74 ↗

December 29, 2023

Amgen stock saw a positive improvement to its Relative Strength (RS) Rating on Friday, with an upgrade from 69 to 74.

On Thursday, Cytokinetics stock cleared a key performance benchmark, with its Relative Strength Rating jumping to 99 from 89 the day before.

Cytokinetics Stock Jumps To Higher RS Level; Shoots Up On Heart Drug Study ↗

December 28, 2023

On Thursday, Ultragenyx Pharm stock received a positive adjustment to its Relative Strength (RS) Rating, from 77 to 81.

Ultragenyx Pharm Stock Hits 80-Plus Relative Strength Rating Benchmark ↗

December 28, 2023

On Tuesday, Recursion Pharm stock reached a key technical benchmark, seeing its Relative Strength Rating jump to 91 from 88 the day before.

Recursion Pharm Showing Market Leadership As Biotech Stocks Shoot Higher ↗

December 26, 2023

So far 2023 is going well with our game plan -an end-of-year seasonal rally coupled with a run in speculative biotechs driven by innovation.

Small Caps Are On A Tear Including Speculative Biotechs ↗

December 26, 2023

Via Talk Markets

Why CarMax Shares Are Trading Higher By Around 8%? Here Are Other Stocks Moving In Thursday's Mid-Day Session ↗

December 21, 2023

Shares of CarMax, Inc. (NYSE: KMX) moved higher during Thursday’s session following better-than-expected quarterly earnings.

Via Benzinga

7 Undervalued Biotech Stocks That are Flying Under the Clinical Radar ↗

December 17, 2023

While the broader healthcare sector offers myriad opportunities, these undervalued biotech picks could offer robust upside.

The no-cost trading platform's customers have their clear favorites, and they're more mainstream names than you might expect them to be.

3 Robinhood Stocks to Buy Right Now ↗

November 05, 2023

These diamonds in the rough won't stay down.

2 Robinhood Stocks With Market-Beating Potential ↗

October 14, 2023

A defensive stock is a stock that demonstrates relatively stable performance regardless of the current state of the economy. Defensive stocks are less prone to the economic cycle of expansions and...

10 Best Defensive Stocks To Invest In 2023 ↗

October 11, 2023

Via Talk Markets

Topics Economy

Vertex Pharmaceuticals Stock Shows Rising Relative Strength, Hits 80+ ↗

August 16, 2023

Vertex Pharmaceuticals shows improving price performance, earning an upgrade to its IBD Relative Strength Rating from 78 to 81.

One key metric to look for in a stock is an 80-plus Relative Strength Rating. ACELYRIN stock hit that mark on Tuesday, with a jump to 81.

ACELYRIN Stock Scores Relative Strength Rating Upgrade; Hits Key Threshold ↗

August 15, 2023

A Relative Strength Rating upgrade for Axsome Therapeutics shows improving technical performance.

Axsome Therapeutics Stock Earns Relative Strength Rating Upgrade ↗

August 15, 2023